526 related articles for article (PubMed ID: 10843150)
1. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
Gower BA; Nagy TR; Goran MI; Smith A; Kent E
J Clin Endocrinol Metab; 2000 May; 85(5):1770-5. PubMed ID: 10843150
[TBL] [Abstract][Full Text] [Related]
2. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement.
Munoz J; Derstine A; Gower BA
Obes Res; 2002 Jun; 10(6):424-31. PubMed ID: 12055317
[TBL] [Abstract][Full Text] [Related]
3. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women.
Thomas T; Burguera B; Melton LJ; Atkinson EJ; O'Fallon WM; Riggs BL; Khosla S
Metabolism; 2000 Oct; 49(10):1278-84. PubMed ID: 11079816
[TBL] [Abstract][Full Text] [Related]
4. Body composition modulates the effects of hormone replacement therapy on growth hormone and insulin-like growth factor-I levels in postmenopausal women.
Figueroa A; Going SB; Milliken LA; Blew R; Sharp S; Lohman TG
Gynecol Obstet Invest; 2002; 54(4):201-6. PubMed ID: 12592062
[TBL] [Abstract][Full Text] [Related]
5. Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women.
Sites CK; Brochu M; Tchernof A; Poehlman ET
Metabolism; 2001 Jul; 50(7):835-40. PubMed ID: 11436191
[TBL] [Abstract][Full Text] [Related]
6. Leptin and body composition in healthy postmenopausal women.
Martini G; Valenti R; Giovani S; Campagna S; Franci B; Nuti R
Panminerva Med; 2001 Sep; 43(3):149-54. PubMed ID: 11579326
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women.
Kristensen K; Pedersen SB; Vestergaard P; Mosekilde L; Richelsen B
J Endocrinol; 1999 Oct; 163(1):55-62. PubMed ID: 10495407
[TBL] [Abstract][Full Text] [Related]
8. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
Tommaselli GA; Di Carlo C; Di Spiezio Sardo A; Bifulco G; Cirillo D; Guida M; Capasso R; Nappi C
Menopause; 2006; 13(4):660-8. PubMed ID: 16837888
[TBL] [Abstract][Full Text] [Related]
9. Effects of exercise training and hormone replacement therapy on lean and fat mass in postmenopausal women.
Figueroa A; Going SB; Milliken LA; Blew RM; Sharp S; Teixeira PJ; Lohman TG
J Gerontol A Biol Sci Med Sci; 2003 Mar; 58(3):266-70. PubMed ID: 12634293
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women.
Ryan AS; Nicklas BJ; Berman DM
Diabetes Care; 2002 Jan; 25(1):127-33. PubMed ID: 11772913
[TBL] [Abstract][Full Text] [Related]
11. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
Sørensen MB; Rosenfalck AM; Højgaard L; Ottesen B
Obes Res; 2001 Oct; 9(10):622-6. PubMed ID: 11595778
[TBL] [Abstract][Full Text] [Related]
12. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
[TBL] [Abstract][Full Text] [Related]
13. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
[TBL] [Abstract][Full Text] [Related]
14. Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release.
Roemmich JN; Clark PA; Lusk M; Friel A; Weltman A; Epstein LH; Rogol AD
Int J Obes Relat Metab Disord; 2002 May; 26(5):701-9. PubMed ID: 12032756
[TBL] [Abstract][Full Text] [Related]
15. Serum leptin levels are reduced in response to exercise training, but not hormone replacement therapy, in older women.
Kohrt WM; Landt M; Birge SJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):3980-5. PubMed ID: 8923847
[TBL] [Abstract][Full Text] [Related]
16. The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial.
Sites CK; L'Hommedieu GD; Toth MJ; Brochu M; Cooper BC; Fairhurst PA
J Clin Endocrinol Metab; 2005 May; 90(5):2701-7. PubMed ID: 15687338
[TBL] [Abstract][Full Text] [Related]
17. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy.
Salbach B; Nawroth PP; Kübler W; von Holst Th; Salbach PB
Eur J Med Res; 2000 Feb; 5(2):63-6. PubMed ID: 10720565
[TBL] [Abstract][Full Text] [Related]
18. Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women.
Gower BA; Nyman L
J Clin Endocrinol Metab; 2000 Dec; 85(12):4476-80. PubMed ID: 11134096
[TBL] [Abstract][Full Text] [Related]
19. Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women.
Brochu M; Starling RD; Tchernof A; Matthews DE; Garcia-Rubi E; Poehlman ET
J Clin Endocrinol Metab; 2000 Jul; 85(7):2378-84. PubMed ID: 10902782
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal associations of the endocrine environment on fat partitioning in postmenopausal women.
Goss AM; Darnell BE; Brown MA; Oster RA; Gower BA
Obesity (Silver Spring); 2012 May; 20(5):939-44. PubMed ID: 22173571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
